Institution statistics

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR - Italy 

Ranking results:

Past rankings:
2015
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Networking Rank (Reputation):600-700
Partner Constancy:700-800
Project Leadership Index:700-800
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:700-800
Total Number of Projects:700-800
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:900-1000
Project Leadership Index:900-1000
Diversity Index:500-600
2010
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
Total Project Funding:100-200
Networking Rank (Reputation):100-200
Partner Constancy:400-500
Project Leadership Index:800-900
Diversity Index:600-700
2009
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:100-200
Total Number of Projects:300-400
Total Project Funding:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:900-1000
Diversity Index:500-600
2008
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:400-500
Project Leadership Index:96
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Total Project Funding:100-200
Networking Rank (Reputation):300-400
Partner Constancy:200-300
Project Leadership Index:100-200
Diversity Index:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 40
As coordinator: 0
As participant: 39
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 2.593.761 538.125 1
2015 0 26.884.132 2.517.625 6
2013 0 4.845.089 536.806 1
2012 0 6.181.084 375.000 2
2011 0 18.564.964 691.370 7
2010 75.000 159.196.079 7.785.032 1 22
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
OSPEDALE SAN RAFFAELE15
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE8
UNIVERSITY COLLEGE LONDON8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE6
KAROLINSKA INSTITUTE6
KING'S COLLEGE LONDON6
MILTENYI BIOTEC6
UNIVERSITA DEGLI STUDI DI VERONA6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
KATHOLIEKE UNIVERSITEIT LEUVEN5
CONSIGLIO NAZIONALE DELLE RICERCHE4
MEDIZINISCHE UNIVERSITAET WIEN4
TALLINNA TEHNIKAULIKOOL4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
THE UNIVERSITY OF LIVERPOOL4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITE DE PARIS VII DENIS DIDEROT4
VRIJE UNIVERSITEIT BRUSSEL4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA3
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE3
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO3
OSPEDALE PEDIATRICO BAMBINO GESU3
UNIVERSITA VITA SALUTE SAN RAFFAELE3
UNIVERSITAT BASEL3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS GRONINGEN2
ACADEMISCH ZIEKENHUIS LEIDEN2
ACCELERON MEDICINES2
ALDEBARAN ROBOTICS SAS2
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA2
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES2
ASPETE HIGHER SCHOOL OF PEDAGOGIC & TECHNOLOGICAL EDUCATION2
ASSOCIATION EUROPEENNE CONTRE LES LEUCODYSTROPHIES2
ATOS SPAIN2
AXCENTUA PHARMACEUTICALS AB2
BAYER PHARMA2
BETA CELL2
CANCER RESEARCH UK2
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES2
CLINIT2
CONCENTRIS RESEARCH MANAGEMENT2
CORETHERAPIX SL2
COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH2
DANDO WEISS & COLUCCI LIMITED2
DEUTSCHES FORSCHUNGSZENTRUM FUER KUENSTLICHE INTELLIGENZ2
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
ELECTRO SCIENTIFIC INDUSTRIES EUROPE2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
ERNSTMORITZARNDTUNIVERSITAET GREIFSWALD2
EUROPEAN AIDS TREATMENT GROUP EV2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
FONDATION MINTAKA POUR LA RECHERCHE MEDICALE2
FONDAZIONE SANTA LUCIA2
FONDAZIONE TELETHON2
FORCE DIMENSION SARL2
FRANCE EUROPE INNOVATION2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
GILEAD SCIENCES INC2
GOSTAI SAS2
HMGBIOTECH S R L2
HOLOGRAFIKA HOLOGRAMELOALLITO FEJLESZTO ES FORGALMAZO KFT2
IBM RESEARCH2
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE2
INSTITUT CURIE2
INSTITUTO DE SALUD CARLOS III2
INTERNATIONAL PARTNERSHIP FOR MICROBICIDES INC2
IRCCS ASSOCIAZIONE LA NOSTRA FAMIGLIA 'ISTITUTO SCIENTIFICO EUGENIO MEDEA'2
ISTITUTO GIANNINA GASLINI2
ITALFARMACO2
JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA JANSSEN INFECTIOUS DISEASES BVBA JANSSEN DIAGNOSTICS BVBA2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
JUVENILE DIABETES RESEARCH FOUNDATION CENTER FOR BETA CELL THERAPY IN DIABETES2
KARLSRUHER INSTITUT FUER TECHNOLOGIE2
KLINIKUM DER UNIVERSITAET REGENSBURG2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
LAB 21 LIMITED2
LIVERPOOL JOHN MOORES UNIVERSITY2
LOUGHBOROUGH UNIVERSITY2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MICROBIOTEC2
MIDDLESEX UNIVERSITY2
MINERVA CONSULTING & COMMUNICATION2
NATIMAB THERAPEUTICS2
NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY2
NOVARTIS PHARMA2
OSLO UNIVERSITETSSYKEHUS HF2
PARTICLE SCIENCES INC2
PHARMATCHING2
PHILIPPS UNIVERSITAET MARBURG2
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG2
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE2
REGION HOVEDSTADEN2
SANTHERA PHARMACEUTICALS2
SARL ENDOCELLS2
Constancy:

Total number of partners:463

Partner loyalty:
Frequent Partner: (> 2 projects): 137
Rare Partner: 326

Frequent / Rare Partner Ratio: 0.42

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES11
RTD HORIZONTAL TOPICS7
SOCIAL AND ECONOMIC CONCERNS6
INDUSTRY AND TECHNOLOGY6

Project overview:

Start dateProjectacronymrolefundingpartners
2016-07-01Intelligent Sensor Enabled Eyewear I-SEEparticipant2.593.7615
2015-06-01Social innovation and light electric vehicle revolution on streets and ambient Silver Streamparticipant3.990.11110
2015-05-01Online Privacy Enforcement, Rights Assurance and Optimization OPERANDOparticipant3.746.0379
2015-03-01Personal Assistant for healthy Lifestyle (PAL) PALparticipant4.515.46011
2015-02-01PRIvacy and Security MAintaining services in the CLOUD PRISMACLOUDparticipant7.983.00916
2015-01-01empoWering prIvacy and securiTy in non-trusteD envirOnMents WITDOMparticipant2.764.0317
2015-01-01Trusted Apps for open CPS TAPPSparticipant3.885.4849
2013-10-01PROBING THE ROLE OF SODIUM CHANNELS IN PAINFUL NEUROPATHIES PROPANE STUDYparticipant4.845.0899
2012-12-01Adoptive engineered T cell Trials to Achieve Cancer Killing ATTACKparticipant6.000.00016
2012-04-16Quantifying transcription factor search mechanism by three-dimensional single molecule tracking SMT of TFsparticipant181.0842
2011-04-01Effect of PTPN22 on Treg to Teff equilibrium in human and murine autoimmune diabetes PTPN22 in T1Dparticipant100.0002
2011-03-01Intelligent Surgical Robotics I-SURparticipant2.980.0009
2011-03-01Intelligent Surgical Robotics I-SURparticipant2.980.0009
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2011-01-01EUROCANCER STEMCELL TRAINING NETWORK EuroCSCTrainingparticipant3.252.48210
2011-01-01EUROCANCER STEMCELL TRAINING NETWORK EuroCSCTrainingparticipant3.252.48210
2010-11-01Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency CELL-PIDparticipant11.887.73520
2010-11-01A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation THE ONE STUDYparticipant10.836.20116
2010-11-01A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation THE ONE STUDYparticipant10.836.20116
2010-10-01Trustworthy Clouds – Privacy and Resilience for Internet-scale Critical Infrastructure TCLOUDSparticipant7.500.00016
2010-10-01Linking research organisations in the fields of Tissue Engineering and Regenerative Medicine through European cooperation between regional research clusters TERMparticipant2.497.73815
2010-10-01Leukemic Stem Cells in Chronic Lymphocytic Leukemia LSC CLLcoordinator75.0001
2010-09-01Experiential Living Lab for the Internet Of Things ELLIOTparticipant2.888.92913
2010-09-01Imaging liver immunopathology by intravital microscopy (IVM): a new approach to study the pathogenesis of hepatitis B virus (HBV) infection Liver IVM and HBVparticipant2.046.2002
2010-07-01Immunomodulatory Effects of Exercise in Type 1 Diabetes IMMEEDIAparticipant399.6005
2010-05-01Role of secretases in myelination Secretases & Myelinparticipant100.0002
2010-05-01Towards Safe and Effective Hematopoietic Stem Cell Gene Therapy: Targeting Integration to Genomic Safe Harbors and Exploiting Endogenous microRNA to Regulate Transgene Expression TARGETINGGENETHERAPYparticipant2.500.0003
2010-04-01Patient Safety in Robotic Surgery SAFROSparticipant3.889.03312
2010-04-01Patient Safety in Robotic Surgery SAFROSparticipant3.889.03312
2010-03-01Adaptive Strategies for Sustainable Long-Term Social Interaction ALIZ-Eparticipant8.287.00012
2010-03-01Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials LeukoTreatparticipant5.978.12625
2010-03-01Adaptive Strategies for Sustainable Long-Term Social Interaction ALIZ-Eparticipant8.287.00012
2010-03-01Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials LeukoTreatparticipant5.978.12625
2010-01-01Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue Endostemparticipant11.997.58022
2010-01-01Combined Highly Active Anti-retroviral Microbicides CHAARMparticipant11.999.99834
2010-01-01Beta Cell Therapy in Diabetes BETACELLTHERAPYparticipant11.700.00018
2010-01-01Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue Endostemparticipant11.997.58022
2010-01-01Beta Cell Therapy in Diabetes BETACELLTHERAPYparticipant11.700.00018
2010-01-01Combined Highly Active Anti-retroviral Microbicides CHAARMparticipant11.999.99834

Alias institution names:
  • FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum